RXO - Company ID 0001929561
The table below shows RXO, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.74B | $4.55B | $3.93B | $4.80B | $4.69B | $3.36B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $832.00M |
RXO, Inc. reported annual revenue of $5.74B for fiscal year 2025. That is up 26.2% from $4.55B in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $3.36B (FY 2020) to $5.74B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $666.00M |
| $591.00M |
| $640.00M |
| $539.00M |
| $455.00M |
| Operating income | -$79.00M | -$56.00M | $39.00M | $123.00M | $192.00M | $60.00M |
| Income tax | -$15.00M | -$14.00M | $0.00 | $27.00M | $41.00M | $14.00M |
| Net income | -$100.00M | -$290.00M | $4.00M | $92.00M | $150.00M | $43.00M |
| EPS (diluted) | -$0.59 | -$2.17 | $0.03 | $0.79 | $1.30 | $0.37 |